← Back to Treatments
🏅 FDA Orphan Designation

Halfan

Halofantrine

Manufacturer: SmithKline Beecham Pharmaceuticals

Indicated for:📚 OBSOLETE: Bacterial susceptibility due to TLR signaling pathway deficiency

Indications & Usage

Treatment of adults who can tolerate oral medication and who have mild to moderate malaria caused by Plasmodium falciparum or Plasmodium vivax.

💙 Support Programs

View all →
Halfan
SmithKline Beecham Pharmaceuticals
Halfan
SmithKline Beecham Pharmaceuticals

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.